CAd3-ZEBOV
id:
cad3-zebov-178-5202451
title:
CAd3-ZEBOV
text:
cAd3-ZEBOV was an experimental vaccine for two ebolaviruses, Ebola virus and Sudan virus, developed by scientists at GlaxoSmithKline (GSK) and tested by National Institute of Allergy and Infectious Disease (NIAID). This vaccine is derived from a chimpanzee adenovirus, Chimp Adenovirus type 3 (ChAd3), genetically engineered to express glycoproteins from the Zaire and Sudan species of ebolavirus to provoke an immune response against them. Simultaneous phase 1 trials of this vaccine commenced in Se
brand slug:
wiki
category slug:
encyclopedia
description:
Experimental vaccine for ebolaviruses
original url:
https://en.wikipedia.org/wiki/CAd3-ZEBOV
date created:
2014-10-14T06:37:07Z
date modified:
2024-09-04T10:50:11Z
main entity:
{"identifier":"Q18162120","url":"https://www.wikidata.org/entity/Q18162120"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/3/3f/Ebola_virus_em.png","width":2043,"height":2887}
fields total:
13
integrity:
16